These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3540918)

  • 1. Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration.
    Hollanders D
    Postgrad Med J; 1986 Jan; 62(723):19-21. PubMed ID: 3540918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
    Lam SK; Lee NW; Koo J; Hui WM; Fok KH; Ng M
    Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colloidal bismuth subcitrate as coated tablets: four times versus twice daily dosage in duodenal ulcer.
    Lazzaroni M; Parente F; Prada A; Bianchi Porro G
    Scand J Gastroenterol Suppl; 1986; 122():51-3. PubMed ID: 3535022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
    Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
    Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
    Shreeve DR; Klass HJ; Jones PE
    Digestion; 1983; 28(2):96-101. PubMed ID: 6360774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.
    Martin DF; Hollanders D; May SJ; Ravenscroft MM; Tweedle DE; Miller JP
    Lancet; 1981 Jan; 1(8210):7-10. PubMed ID: 6109102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers.
    Lee FI; Samloff IM; Hardman M
    Lancet; 1985 Jun; 1(8441):1299-302. PubMed ID: 2860494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato-bismuthate.
    Lee SP; Nicholson GI
    Med J Aust; 1977 May; 1(22):808-12. PubMed ID: 329077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
    Lacey LF; Frazer NM; Keene ON; Smith JT
    Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
    Dunk AA; Prabhu U; Tobin A; O'Morain C; Mowat NA
    Aliment Pharmacol Ther; 1990 Apr; 4(2):157-62. PubMed ID: 2104081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Ardizzone S; Manzionna G; Caruso I; Montrone F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):343-7. PubMed ID: 9690723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers.
    Bianchi Porro G; Parente F; Lazzaroni M
    Gut; 1987 Jul; 28(7):907-11. PubMed ID: 3308650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1024-5. PubMed ID: 4048901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
    Sutton DR
    Gut; 1982 Jul; 23(7):621-4. PubMed ID: 7044913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trial.
    Glover SC; Cantlay JS; Weir J; Mowat NA
    Dig Dis Sci; 1983 Jan; 28(1):13-7. PubMed ID: 6185289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer.
    Lazzaroni M; Petrillo M; Bianchi Porro G
    Br J Clin Pract; 1989 Apr; 43(4):151-5. PubMed ID: 2590626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
    Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
    Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.